Mrv1718007031819022D 17 19 0 0 0 0 999 V2000 3.2056 0.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2056 -0.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4912 -0.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7766 -0.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7766 0.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4912 1.1270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9920 0.9695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.5070 0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9920 -0.3654 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -0.3179 0.3019 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -0.7305 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.5555 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9680 -1.1270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7931 -1.1270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2056 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7931 0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9680 0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 1 6 1 0 0 0 0 5 7 1 0 0 0 0 7 8 2 0 0 0 0 8 9 1 0 0 0 0 4 9 1 0 0 0 0 8 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 12 17 1 0 0 0 0 M END > DB14200 > drugbank > C1CCC(CC1)NSC1=NC2=CC=CC=C2S1 > InChI=1S/C13H16N2S2/c1-2-6-10(7-3-1)15-17-13-14-11-8-4-5-9-12(11)16-13/h4-5,8-10,15H,1-3,6-7H2 > DEQZTKGFXNUBJL-UHFFFAOYSA-N > C13H16N2S2 > 264.41 > 264.075490871 > 2 > 33 > 30.058688096116676 > 1 > 1 > 0 > 1 > N-(1,3-benzothiazol-2-ylsulfanyl)cyclohexanamine > 3.98 > 4.617399854333334 > -4.29 > 0 > 3 > 0 > 6.0844991807964695 > 24.92 > 82.3999 > 3 > 1 > 1.35e-02 g/l > N-(1,3-benzothiazol-2-ylsulfanyl)cyclohexanamine > 1 > DB14200 > approved; experimental > Thiohexam > 2-(Cyclohexylaminothio)benzothiazole; 2-Benzenethiazolesulfenamide, N-cyclohexyl-; Benzothiazyl-2-cyclohexylsulfenamide; Cyclohexyl benzothiazolesulfenamide; N-cyclohexyl-2-Benzothiazosulfenamide; N-Cyclohexylbenzothiazol-2-sulfenamid > T.R.U.E. Test Thin-Layer Rapid Use Patch Test $$$$